Mediplexus Co., Ltd. (CEO Kim Dong-gyu) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
Mediplexus is a medical data-based clinical research platform company. We build an ecosystem for precision medical research targeting hospitals, pharmaceutical and bio companies, clinical trial consignment agencies, and government agencies, and provide various medical data utilization services. The company explains that this contributes to the development of precision medicine research and also plays a mediating role in enabling healthcare companies and clinicians to cooperate for products desired by patients.
In this exhibition, Mediplexus introduces ‘AllRe’, a high-level medical data analysis solution that was developed and launched in-house last year. It consists of a disease-specific database and analysis program, and focuses on analyzing medical data and discovering real-world evidence (RWE).
Ollie has differentiated advantages based on its functional characteristics. First of all, variables and algorithms suitable for analysis are customized for each disease according to the researchers’ requirements, enabling practical, high-level analysis, and the usability of the analysis information is also excellent. In addition, it was developed with a user-centered and convenient UI/UX, and the analysis that existing researchers would take at least several months can be completed in one day.
A Mediplex official said, “The idea for developing Olli was to utilize medical data (EMR) from clinical sites for successful clinical trials and precision medicine research.” He added, “The objective evidence needed for clinical trials and precision medicine research. The clinical evidence required ultimately refers to evidence of actual use. “Oli Solutions provides professional database construction and analysis programs to secure evidence of actual use,” he added.
“Furthermore, our company is working with an accounting firm that was in charge of evaluating data in other fields last year to develop a medical data asset evaluation model this year,” he said. “This year, a medical data asset evaluation report will be released for hospitals and pharmaceutical companies that have adopted the Olli solution.” “It is scheduled to be issued, and we expect that various business applications will emerge in the biohealth market through this,” he said of his future plans.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.